logo
ProjectArchived

Innovative and Applied Emerging Technologies in Biospecimen Science (R33)

Archived · United States of America

Source: Grants.gov

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science.

Status
Closed
Sector
Education, Power Transmission, Government, Power Generation (CCGT)
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about Innovative and Applied Emerging Technologies in Biospecimen Science (R33)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Innovative and Applied Emerging Technologies in Biospecimen Science (R33)” is an infrastructure initiative in the Education sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science. The overall goal is to develop and evaluate technologies capable of interrogating or maximizing the quality and utility of biospecimens for molecular analyses with minimal invasiveness or compromise to donor/patient health. This FOA will also support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. Projects must clearly demonstrate potential to produce a major impact in the area of biospecimen science. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-09-007.

Budget

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Education, Power Transmission, Government, Power Generation (CCGT)

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project